Healthlead Public Financials

HL Stock   9.90  0.85  9.39%   
You can harness Healthlead Public fundamental data analysis to find out if markets are presently mispricing the company. We have analyzed twenty-six available reported financial drivers for Healthlead Public, which can be compared to its competitors. The stock experiences a very speculative upward sentiment. Check odds of Healthlead Public to be traded at 12.38 in 90 days.
  
Understanding current and past Healthlead Public Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Healthlead Public's financial statements are interrelated, with each one affecting the others. For example, an increase in Healthlead Public's assets may result in an increase in income on the income statement.
Foreign Associate
  USA
InstrumentThailand Stock View All
ExchangeThailand Exchange
Business Address994, Moo 10,
SectorHealthcare
IndustryMedical Distribution
BenchmarkDow Jones Industrial
Websitewww.healthleadgroup.com
Phone66 2 118 0884
You should never invest in Healthlead Public without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Healthlead Stock, because this is throwing your money away. Analyzing the key information contained in Healthlead Public's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Healthlead Public Key Financial Ratios

Healthlead Public's financial ratios allow both analysts and investors to convert raw data from Healthlead Public's financial statements into concise, actionable information that can be used to evaluate the performance of Healthlead Public over time and compare it to other companies across industries.

Healthlead Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Healthlead Public's current stock value. Our valuation model uses many indicators to compare Healthlead Public value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Healthlead Public competition to find correlations between indicators driving Healthlead Public's intrinsic value. More Info.
Healthlead Public is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about  0.52  of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Healthlead Public is roughly  1.93 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Healthlead Public's earnings, one of the primary drivers of an investment's value.

Healthlead Public Systematic Risk

Healthlead Public's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Healthlead Public volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was three with a total number of output elements of fifty-eight. The Beta measures systematic risk based on how returns on Healthlead Public correlated with the market. If Beta is less than 0 Healthlead Public generally moves in the opposite direction as compared to the market. If Healthlead Public Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Healthlead Public is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Healthlead Public is generally in the same direction as the market. If Beta > 1 Healthlead Public moves generally in the same direction as, but more than the movement of the benchmark.

Healthlead Public Thematic Clasifications

Healthlead Public is part of Health Management investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Healthcare providers, hospitals. Major hospitals and healthcare providers
Health ManagementView
This theme covers Healthcare providers, hospitals. Major hospitals and healthcare providers. Get More Thematic Ideas

Healthlead Public December 11, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Healthlead Public help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Healthlead Public. We use our internally-developed statistical techniques to arrive at the intrinsic value of Healthlead Public based on widely used predictive technical indicators. In general, we focus on analyzing Healthlead Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Healthlead Public's daily price indicators and compare them against related drivers.

Other Information on Investing in Healthlead Stock

Healthlead Public financial ratios help investors to determine whether Healthlead Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Healthlead with respect to the benefits of owning Healthlead Public security.